EZLife Bio's Series A Round

EZLife Bio raised a round of funding on April 17, 2017. Investors include Sangel Capital.

EZlife Bio is a diagnostic company specializing in noninvasive precision tumor gene detection based on an apparatus called EFIRM, which was independently developed by the company. In the past, it was …

Articles about EZLife Bio's Series A Round: